s6y
Company name or ticker
Search
Syros Pharmaceuticals, Inc.
8-K
Material agreement; New debt or obligation; Other events
Filed
Thursday, February 13, 2020
Period
Feb 12, 2020
Accession number
0001193125-20-034397
Documents
Current report filing
8-K
99.1
Press release or other material
EX-99.1
Exhibits
1.1
Underwriting agreement
EX-1.1
On sec.gov
Filing index
All files
Complete submission text
SGML header